Category : Functional Disorders

The enteric nervous system (ENS)—also called “our second brain”—is an autonomous part of the nervous system consisting of in the myenteric and submucosal plexus within the wall of the gastrointestinal tract. Comprising primary afferent neurons, interneurons and motor neurons, alongside intestinal cells involved in immune responses and endocrine and paracrine functions, it is involved in the sensory-motor control of the…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

The enteric nervous system (ENS)—also called “our second brain”—is an autonomous part of the nervous system consisting of in the myenteric and submucosal plexus within the wall of the gastrointestinal tract. Comprising primary afferent neurons, interneurons and motor neurons, alongside intestinal cells involved in immune responses and endocrine and paracrine functions, it is involved in the sensory-motor control of the…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

A current challenge in gut microbiome science is that of characterizing the effects of food groups on gut microbial communities instead of focusing on isolated nutrients. Although prebiotics provide health benefits by specifically altering the composition or activity of the gut microbiota, not all dietary fibers are prebiotics and they can benefit gut bacterial groups in different ways. A new…

GMFH Editing Team
GMFH Editing Team

A current challenge in gut microbiome science is that of characterizing the effects of food groups on gut microbial communities instead of focusing on isolated nutrients. Although prebiotics provide health benefits by specifically altering the composition or activity of the gut microbiota, not all dietary fibers are prebiotics and they can benefit gut bacterial groups in different ways. A new…

GMFH Editing Team
GMFH Editing Team

Specific dietary modifications have been an area of focus to treat a myriad of diseases such as obesity and IBS. However, the individual response to dietary interventions can vary greatly, partly due to our unique gut microbiota compositions. Personalized nutrition is a promising area of research that aims to predict physiological response to dietary interventions based on a person's gut microbial…

Allison Clark
Allison Clark has a master in nutrition and health from Open University in Barcelona and a master in journalism. She is a freelance writer and nutritionist and has written various peer review papers about the role the gut microbiota plays in health, disease and endurance exercise performance. Allison is passionate about the role diet and the gut microbiota play in health and disease. Follow her on Twitter @Heal_your_Gut

Specific dietary modifications have been an area of focus to treat a myriad of diseases such as obesity and IBS. However, the individual response to dietary interventions can vary greatly, partly due to our unique gut microbiota compositions. Personalized nutrition is a promising area of research that aims to predict physiological response to dietary interventions based on a person's gut microbial…

Allison Clark
Allison Clark has a master in nutrition and health from Open University in Barcelona and a master in journalism. She is a freelance writer and nutritionist and has written various peer review papers about the role the gut microbiota plays in health, disease and endurance exercise performance. Allison is passionate about the role diet and the gut microbiota play in health and disease. Follow her on Twitter @Heal_your_Gut

Over 350 physicians, dietitians, nutritionists, advanced practice providers and researchers from 49 countries gathered in Miami (USA), on March 23-24, for the 8th edition of the Gut Microbiota for Health World Summit 2019, where world-renowned experts in the field discussed the latest evidence on the interaction between diet, nutrition and the gut microbiome. With Gail Hecht and Francisco Guarner as…

GMFH Editing Team
GMFH Editing Team

Over 350 physicians, dietitians, nutritionists, advanced practice providers and researchers from 49 countries gathered in Miami (USA), on March 23-24, for the 8th edition of the Gut Microbiota for Health World Summit 2019, where world-renowned experts in the field discussed the latest evidence on the interaction between diet, nutrition and the gut microbiome. With Gail Hecht and Francisco Guarner as…

GMFH Editing Team
GMFH Editing Team

Mental health-related conditions such as anxiety and depression have been found to be more frequent in adults with functional gastrointestinal disorders that include irritable bowel syndrome. Although these findings suggest a close relationship between mental illness and functional gastrointestinal symptoms, little is known about the extent to which these manifestations may share a common etiology, especially in early life, when…

GMFH Editing Team
GMFH Editing Team

Mental health-related conditions such as anxiety and depression have been found to be more frequent in adults with functional gastrointestinal disorders that include irritable bowel syndrome. Although these findings suggest a close relationship between mental illness and functional gastrointestinal symptoms, little is known about the extent to which these manifestations may share a common etiology, especially in early life, when…

GMFH Editing Team
GMFH Editing Team

We know that the gut microbiome is thought to be involved in the pathogenesis of functional gastrointestinal disorders. However, even though underlying mechanisms are poorly understood, small intestinal bacterial overgrowth (SIBO) could contribute to explaining some gastrointestinal symptoms in patients with these conditions. The field's primary challenges include characterizing the small intestinal microbiome and exploring to what extent diet-driven changes…

GMFH Editing Team
GMFH Editing Team

We know that the gut microbiome is thought to be involved in the pathogenesis of functional gastrointestinal disorders. However, even though underlying mechanisms are poorly understood, small intestinal bacterial overgrowth (SIBO) could contribute to explaining some gastrointestinal symptoms in patients with these conditions. The field's primary challenges include characterizing the small intestinal microbiome and exploring to what extent diet-driven changes…

GMFH Editing Team
GMFH Editing Team

Over the past 15 years, scientists have focused mainly on the bacterial fraction of the gut microbiome to characterize its composition and impact on human health and diseases. Despite this, fungi, phages, archaea and protists also count as native constituents of the microbiome, and now, scientists have also started to take an interest in their physiological relevance. Recent studies support…

GMFH Editing Team
GMFH Editing Team

Over the past 15 years, scientists have focused mainly on the bacterial fraction of the gut microbiome to characterize its composition and impact on human health and diseases. Despite this, fungi, phages, archaea and protists also count as native constituents of the microbiome, and now, scientists have also started to take an interest in their physiological relevance. Recent studies support…

GMFH Editing Team
GMFH Editing Team

Traditionally, the diet low in fermentable oligo-, di-, and monosaccharide and polyol (FODMAP) - best as a 2-phased intervention, with strict reduction of all slowly absorbed or indigestible carbohydrates (i.e., FODMAPs) followed by reintroduction of some of them according to tolerance - has been widely used for overall gastrointestinal symptom relief in patients with irritable bowel syndrome (IBS). However, decreasing…

Andrea Hardy
Registered Dietitian, Andrea Hardy from Calgary, Canada specializes in gastrointestinal disorders and the gut microbiome. She is recognized as Canada’s gut health dietitian – educating health care professionals and the public on the pivotal role nutrition plays in gut health. You can find her at Ignite Nutrition, or on Twitter (@AndreaHardyRD).

Traditionally, the diet low in fermentable oligo-, di-, and monosaccharide and polyol (FODMAP) - best as a 2-phased intervention, with strict reduction of all slowly absorbed or indigestible carbohydrates (i.e., FODMAPs) followed by reintroduction of some of them according to tolerance - has been widely used for overall gastrointestinal symptom relief in patients with irritable bowel syndrome (IBS). However, decreasing…

Andrea Hardy
Registered Dietitian, Andrea Hardy from Calgary, Canada specializes in gastrointestinal disorders and the gut microbiome. She is recognized as Canada’s gut health dietitian – educating health care professionals and the public on the pivotal role nutrition plays in gut health. You can find her at Ignite Nutrition, or on Twitter (@AndreaHardyRD).

Previous research has shown that some subgroups of patients with irritable bowel syndrome (IBS) exhibit a different gut microbiota composition. Although previous small not blinded studies and one randomized placebo-controlled study have looked at the effectiveness of fecal microbiota transplantation (FMT) in patients with IBS, its utility in these patients remains unknown. A new randomized, double-blind placebo-controlled study, led by…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Previous research has shown that some subgroups of patients with irritable bowel syndrome (IBS) exhibit a different gut microbiota composition. Although previous small not blinded studies and one randomized placebo-controlled study have looked at the effectiveness of fecal microbiota transplantation (FMT) in patients with IBS, its utility in these patients remains unknown. A new randomized, double-blind placebo-controlled study, led by…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.